Grants and Contributions

About this information

In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.

The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.

Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.

Found 2124 records

$264,000.00

Mar 27, 2024

Academia

Agreement:

The Digital Mouse – a digital twin of behavioral indices of neurodegeneration and associated metabolic determinants for explainable in silico therapy design

Agreement Number:

1010082

Duration: from Mar 27, 2024 to Mar 31, 2026
Description:

The driving hypothesis of this project is that a digital mouse developed through optimized AI approaches and extensive, available biological data can provide a framework to support the design of evidence- based therapies for neurodegenerative diseases. The main outcome of this project will be an in silico reconstruction and simulation of the dependence of behavior, as a measure of neurodegeneration, on the lipidome and its application in corrective intervention development.

Organization: National Research Council Canada
Program Name: Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Location: Kingston, Ontario, CA K7L 3N6

$25,000.00

Mar 27, 2024

Not-for-profit organization or charity

Agreement:

Allowing gene correction therapy for sickle cell disease patients using advances in lipid nanoparticle formulation

Agreement Number:

1015395

Duration: from Mar 27, 2024 to Sep 30, 2025
Description:

Advances exploratory research under the New Beginnings Initiative

Organization: National Research Council Canada
Program Name: Collaborative Science, Technology and Innovation Program – Ideation Fund
Location: Ottawa, Ontario, CA K1G 4J5

For-profit organization

Description:

Develop digital adoption plan

Organization: Innovation, Science and Economic Development Canada
Program Name: Canadian Digital Adoption Program Boost your Business Technology Stream
Location: HALIFAX, Nova Scotia, CA B3J3T5

For-profit organization

Description:

Develop digital adoption plan

Organization: Innovation, Science and Economic Development Canada
Program Name: Canadian Digital Adoption Program Boost your Business Technology Stream
Location: NANAIMO, British Columbia, CA V9S5W8

$15,000.00

Mar 19, 2024

For-profit organization

Description:

Develop digital adoption plan

Organization: Innovation, Science and Economic Development Canada
Program Name: Canadian Digital Adoption Program Boost your Business Technology Stream
Location: GLOUCESTER, Ontario, CA K1V1H5

$366,946.00

Mar 14, 2024

Academia

Agreement:

AAV Gene Therapy for the Treatment of Lipoprotein Lipase Deficiency

Agreement Number:

1014773

Duration: from Mar 14, 2024 to Mar 1, 2025
Description:

The project will lead to an improved and more cost-effective AAV-LPL gene therapy for the treatment of Lipoprotein Lipase (LPL) Deficiency.

Organization: National Research Council Canada
Program Name: Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Location: Vancouver, British Columbia, CA V6T 1Z3

For-profit organization

Description:

Develop digital adoption plan

Organization: Innovation, Science and Economic Development Canada
Program Name: Canadian Digital Adoption Program Boost your Business Technology Stream
Location: NORTH YORK, Ontario, CA M3B2T5

$691,045.00

Feb 20, 2024

Not-for-profit organization or charity

Agreement:

Development and application of qualified testing in support of Clinical CAR-T Products

Agreement Number:

1015631

Duration: from Feb 20, 2024 to Mar 10, 2026
Description:

In the Project, OHRI will build on their success in establishing clinical grade manufacturing for both lentivirus and cell products, and the execution of the first clinical trial using a made-in-Canada CD19 CAR T-cell therapy. The project includes building capacity in point-of-care (POC) manufacturing to support the clinical rollout of novel CAR T-cell products and other personalized cell therapy products.

Organization: National Research Council Canada
Program Name: Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Location: Ottawa, Ontario, CA K1Y 4E9

$14,175.00

Feb 20, 2024

For-profit organization

Description:

Develop digital adoption plan

Organization: Innovation, Science and Economic Development Canada
Program Name: Canadian Digital Adoption Program Boost your Business Technology Stream
Location: ST. ALBERT, Alberta, CA T8N5T8

$24,894.00

Feb 19, 2024

For-profit organization

Agreement:

Patent Filings for New Applications of Sona Gold Nanorods for Targeted Hyperthermia Therapy and Other Applications

Agreement Number:

1015813

Duration: from Feb 19, 2024 to Dec 31, 2024
Description:

Sona Nanotech Inc. has a patented and patent-pending technology for manufacturing biocompatible, toxin-free gold nanorods. The goal of the intellectual property work outlined in this proposal is to enable Sona to file additional patent(s) covering new capabilities of the nanorods. The deliverables of this project will be a patent landscape report that includes patent search details, patent publication level results, patent assignee analysis, subject matter analysis, country analysis, and date analysis. This report will then be used to formulate and refine a strategy for Sona's next patent filings, starting with provisional patent filings to establish a priority date for the inventions disclosed in the application.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Contributions to Firms
Location: Halifax, Nova Scotia, CA B3J 3R7